__timestamp | AbbVie Inc. | Eli Lilly and Company |
---|---|---|
Wednesday, January 1, 2014 | 3297000000 | 4733600000 |
Thursday, January 1, 2015 | 4285000000 | 4796400000 |
Friday, January 1, 2016 | 4366000000 | 5243900000 |
Sunday, January 1, 2017 | 4982000000 | 5281800000 |
Monday, January 1, 2018 | 10329000000 | 5051200000 |
Tuesday, January 1, 2019 | 6407000000 | 5595000000 |
Wednesday, January 1, 2020 | 6557000000 | 6085700000 |
Friday, January 1, 2021 | 7084000000 | 7025900000 |
Saturday, January 1, 2022 | 6510000000 | 7190800000 |
Sunday, January 1, 2023 | 8453000000 | 9313400000 |
Monday, January 1, 2024 | 0 | 14271000000 |
Igniting the spark of knowledge
In the competitive landscape of pharmaceutical giants, research and development (R&D) spending is a key indicator of innovation and future growth. Over the past decade, Eli Lilly and Company and AbbVie Inc. have been at the forefront of this race. From 2014 to 2023, Eli Lilly's R&D expenses surged by nearly 97%, peaking in 2023 with a remarkable $9.3 billion. Meanwhile, AbbVie, despite a significant 156% increase in R&D spending, reached its highest in 2018 with $10.3 billion.
Eli Lilly consistently increased its R&D investment, particularly from 2020 onwards, reflecting a strategic focus on innovation. AbbVie, on the other hand, experienced a notable spike in 2018, followed by a steady investment pattern. This financial commitment underscores the companies' dedication to pioneering new treatments and maintaining a competitive edge in the pharmaceutical industry.
Analyzing R&D Budgets: Eli Lilly and Company vs Zoetis Inc.
Research and Development: Comparing Key Metrics for Eli Lilly and Company and BeiGene, Ltd.
R&D Insights: How Eli Lilly and Company and Verona Pharma plc Allocate Funds
Research and Development: Comparing Key Metrics for Eli Lilly and Company and Amicus Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Eli Lilly and Company and MiMedx Group, Inc.
Comparing Innovation Spending: Johnson & Johnson and AbbVie Inc.
AbbVie Inc. or Vertex Pharmaceuticals Incorporated: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for AbbVie Inc. and Corcept Therapeutics Incorporated
Research and Development: Comparing Key Metrics for AbbVie Inc. and Alkermes plc
R&D Insights: How AbbVie Inc. and Amneal Pharmaceuticals, Inc. Allocate Funds
AbbVie Inc. vs Perrigo Company plc: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for AbbVie Inc. and Taro Pharmaceutical Industries Ltd.